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Homozygous complement deficiencies have been characterized by the total or near 
total absence of the deficient complement  component. Total absence of the protein 
has also been reported in several  individuals with homozygous  C8 deficiency  (1-3). 
Recently  a  second  form of genetic  C8  deficiency  has  been  described  in  which  an 
antigenically deficient, nonfunctional C8 molecule occurs in the plasma of the afflicted 
individuals  (4-7).  We have  studied  the  abnormal  C8  protein  from three  unrelated 
individuals  with  functional  C8  deficiency  and  a  history  of  recurrent  Neisserial 
infections. The three proteins resembled each other in that they were immunochem- 
ically  indistinguishable,  lacked  one of the chains present  in the normal three-chain 
C8 molecule, and could be functionally reconstituted by providing the missing chain 
isolated  from normal C8.  Parts of this study  have  been  presented  in abstract  form 
(6, 7). 
Materials and Methods 
Sera and  Complement Components.  Plasma samples  from  patients R.S.  and J.C.,  who  had 
recurrent meningocoecal  meningitis,  were prepared at the Center for Disease Control in Atlanta, 
Ga. by standard procedures. Large amounts of plasma from one individual (R.S.) were obtained 
by plasmaphoresis performed by Dr. Michael Frank at the National Institute of Allergy and 
Infectious Diseases. Plasma from the third patient (S.K.), who was suffering from gonococcal 
infections, was supplied by Dr. C. Casavant and Dr. R. Jacobs, University of California, School 
of Medicine, San Francisco. Serum samples were obtained by centrifugation of plasma allowed 
to clot at room temperature for 1 h after addition of CaC12. Normal human serum was prepared 
from  blood  of donors  at  Scripps  Clinic and  Research  Foundation. Complement proteins 
C5b-6, C7, C8, and C9 were isolated as described (8-11). The noncovalently  linked subunits of 
C8, C8a-y and C8fl (10) were isolated as described by Steckel  et  al.  (12). Samples of these 
subunits for  preliminary tests  were  kindly supplied by  Dr.  James  Sodetz,  Department of 
Chemistry, University of South Carolina at Columbus. 
Hemolytic Assays.  Hemolytic assays  of whole serum  (CHs0) were  performed according to 
standard methods (13). C8 activity was measured by adding diluted test serum to human serum 
immunochemically depleted of C8 and by assaying for hemolytic activity as described before 
(10). 
Sedimentation Analysis.  Ultracentrifugation  studies were performed with a model E analytical 
ultracentrifuge (Beckman Instruments, Inc., Fullerton, Calif.) equipped with an optical scanner 
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and a special ultraviolet  light collimator (Schrader, Feinmechanik and Optik,  Braunschweig, 
West  Germany)  allowing  analysis  of very  dilute  protein  samples.  C8  R.S.  or  C8a-y  R.S. 
dissolved in Tris-buffered saline (TBS) 1 (10 mM Tris, 150 mM NaCI, pH 7.4) at a concentration 
of 0.1 mg/ml were sedimented at 52,000 rpm and the sedimentation rate constants (s20.w) were 
calculated according to standard procedures. Equilibrium sedimentation analysis was carried 
out at  12,000 rpm and the protein distribution  in the cell was measured at  280 nm with the 
photoelectric scanner. Molecular weights were determined  (14) from a least-squares fit of log 
A2so vs.  r 2  using a  partial  specific  volume of 0.723  ml/g as calculated  from the amino acid 
composition listed  under Results. 
Sucrose Density Gradient Ultracentrifugation.  Samples were sedimented at 4°C in linear 10-40% 
sucrose density gradients  prepared  in TBS containing  10 mM  EDTA in  an  SW 50.1 rotor 
(Beckman Instruments, Inc.) for 16 h at 37,000 rpm. 
Sodium Dodecyl Sulfate-Polyacrylamide Gel  Electrophoresis (SDSopAGE).  Electrophoresis  was 
carried  out  in  9-cm-long,  1.5-mm-thick  slabs  prepared  from  10%  polyacrylamide  using  a 
discontinuous multiphasic buffer system described by Jovin et al.  (15) (CANALCO Sage Kit; 
Miles Laboratories Inc., Elkhart, Ind.). 
Radioiodination.  Proteins were trace-labeled with x25I by using a solid state system described 
by Fraker and Speck (16) (IODOGEN, Pierce Chemical Co., Rockford, Ill.).  Free iodine was 
removed by gel filtration on 10-ml columns of Sephadex G-25. 
Amino  Acid  Analysis.  Analyses  were  performed  in  a  model  121-M  analyzer  (Beckman 
Instruments,  Inc.)  coupled  to an  Autolab  System  AA computing integrator.  Samples  were 
hydrolyzed for 24 h and half-cystine was determined after oxidation with performic acid. 
Immunochemical Analysis.  Double immunodiffusion in agarose, quantitative radial immuno- 
diffusion,  and  immunoelectrophoresis  were  performed  according to  conventional  methods. 
Antisera to C8 were prepared in rabbits and goats. 
Results 
Detection of Dysfunctional C8 Protein in C8-deficient  Sera.  Plasma samples from patients 
R.S., J.C.,  and S.K. showed no hemolytic activity (CHso). Immunochemical analysis 
revealed  an  apparent  C8  protein  concentration  of 35-44%  of normal.  In  addition, 
plasma R.S. had only 44% of normal C2, whereas plasma S.K. and J.C. had reduced 
levels of C5 (69 and 79% of normal), and plasma S.K. was also low in Factor H  (/~IH) 
(68% of normal). All other complement components in all three sera were within the 
normal range. 2 C8 titrations performed on sera R.S. and J.C. indicated that these sera 
lacked C8 hemolytic activity (Fig.  1) and that both sera therefore contained dysfunc- 
tional C8 protein. The C8 hemolytic activity of the serum of the parents of R.S. was 
approximately one-half the normal value. 
Antigenic Deficiency of the Dysfunctional C8 Protein.  Double immunodiffusion using an 
antiserum to normal C8 revealed complete antigenic identity of the dysfunctional C8 
proteins  in the three  patients' sera and marked  antigenic  deficiency compared with 
normal C8. As shown in Fig. 2, a  reaction of identity was observed between C8 R.S. 
and  C8 J.C.  and  between  C8 J.C.  and  C8  S.K.  In  contrast,  a  pattern  of partial 
identity was formed with C8 in normal serum, with the precipitin  line of normal C8 
spurring heavily over that of the deficient C8 protein.  Upon immunoelectrophoresis, 
the abnormal C8 moved faster than normal C8 (Fig. 3), indicating that the deficient 
C8 had a  charge different from normal C8 at pH 8.6. 
Lack of the t~ Chain in the Abnormal C8 Molecule.  The C8-related protein present  in 
serum  R.S.  was isolated  using  immunoaffinity techniques.  In brief,  serum  R.S.  was 
i Abbreviations used in this paper." SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; 
TBS, Tris-buffered saline. 
A complete report detailing clinical and immunogenetic studies on the families of patients R.S. and 
J.C. will appear elsewhere. TSCHOPP  ET  AL.  1601 
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Fzc.  1.  Comparative  analysis  of C8  hemolytic  activity of sera  from  R.S.  (A), J.C.  (A),  and  from 
the mother  (×)  and the father  (I-q) of R.S.  Normal  human  serum  (0). 
Fxc.  2.  Demonstration of antigenic deficiency of C8 protein in serum from patients R.S.,J.C., and 
S.K. The center well contains goat anti-human C8 serum. N: normal human serum. 
brought to a  10-mM concentration in EDTA and passed over a column of BioRex 70 
(Bio-Rad  Laboratories,  Richmond,  Calif.)  to  remove  Clq  as  described  (17).  The 
material  in  the  column  breakthrough  was  then  applied  to  an  affinity  column 
containing rabbit anti-C8 IgG coupled to CNBr-activated Sepharose 4B. The anti-C8 
selected for this purpose was capable of binding both the a-7 and/~ subunits of normal 
C8. After washing with TBS containing 2 M  NaC1, the column was eluted with TBS 
brought to a  2-M concentration in NaCI and 3 M  in guanidine hydrochloride. The 
material was concentrated, dialyzed, and further purified by gel filtration on Sephac- 
ryl-200. Analysis of C8  R.S.  by SDS-PAGE under nonreducing conditions  (Fig.  4) 
indicated  that  the protein behaved  like  the a-y subunit  of normal  C8  and  that  it 
could be dissociated by reduction into chains resembling the a  and y  chains of C8. 
The t8 chain could not be detected. Evidence that the/~ chain was not lost during the 
purification  procedure,  for example  on  the  BioRex  70  resin,  was  obtained  in  the 
following way. Serum R.S. was incubated overnight with soluble rabbit anti-C8 IgG 
and  the immune complexes formed were precipitated with  an  antiserum  to rabbit 
IgG.  When  the  precipitated  material  was  analyzed by  SDS-PAGE  after extensive 
washing, no band with the electrophoretic mobility of C8/~ could be detected. Further, 
when C8  from normal serum  was  isolated by the immunoaffinity chromatography 
procedure,  all  three  chains  were  obtained.  Using  the  same  procedure,  there  was 1602  INCOMPLETE C8  MOLECULE IN HOMOZYGOUS C8  DEFICIENCY 
FIO. 3.  Immunoelectrophoretic  representation of C8 protein in serum R.S. compared with normal 
C8. Immunoelectrophoresis  was carried out in 1.5% agarose  gel and veronal buffer at pH 8.6. Anode 
was to the right. 
evidence of the C8a-y subunit  but not  the fl chain in serum from patient S.K.  (data 
not shown). 
C8  R.S.  was  subjected  to  sedimentation  equilibrium  analysis  and  a  molecular 
weight  of 86,000  was  determined,  whereas  the  molecular  weight  of normal  C8, 
determined  by the same method, was  151,000.  Both  molecules are similar in  shape 
having frictional coefficients, f/fo, of 1.15  (Table I). The amino acid composition of 
C8 R.S. was not significantly different from that of normal C8a-y (Table II) and was 
independent of the method of isolation. 
Functional Reconstitution of the  Sera  Containing Dysfunctional C8  with  Isolated CSfl 
Chain.  Because C8  R.S.  resembled the a-y subunit  of normal C8,  serum  R.S.  was 
tested for reconstitution of its hemolytic activity by isolated normal C8fl. As shown in 
Fig.  5,  addition  of CSfl but  not  C8a-y to  serum  R.S.  restored  the  total  hemolytic 
activity to normal. C8-depleted serum, tested simultaneously, required the combined 
addition of the a-y and fl subunits for restoration of hemolytic activity. The hemolytic 
activity  of sera  from  patients  S.K.  and J.C.  was  also  restored  by  addition  of the 
isolated fl chain alone. 
Isolated C8  R.S.  was  also  examined  for  its  ability  to  become incorporated  into 
SC5b-9. As shown in Fig. 6, C8 R.S. does not bind to SC5b-7 unless normal fl chain 
is added. Panel A indicates the sedimentation behavior of the SC5b-7 complex formed 
in  C8-depleted  serum upon  addition  of C5b-6.  Panel  B  shows the  SC5b-9 complex 
formed  in  C8-depleted  serum  upon  addition  of C5b-6  plus  excess  C8.  When  12gI- 
C8a-T  was  added  together  with  C5b-6  to  serum  R.S.  and  the  serum  was  then 
centrifuged in a linear sucrose density gradient, the labeled protein remained near the TSCHOPP  ET  AL.  1603 
Fro.  4.  SDS-PAGE analysis of purified C8 R.S. (tracks 1 and 4), normal C8 (tracks 2 and 5), and 
chain isolated from normal C8 (tracks 3 and 6). 
TABLE  I 
Physicochemical Parameters  of Normal C8 and CSa-y R.S.  as Determined  by 
Analytical Ultracentrifugation 
Normal C8  C8a-7 R.S. 
s20.,,  8.2  5.4 
Molecular weight  151,000  86,000 
f/fo*  1.15  1.15 
* A degree of hydration of 0.3 gram water/gram protein was assumed. 
top of the density gradient  (Fig. 6C), indicating that it did not bind to the SC5b-7 
complex that  was  formed. In  contrast, when C8fl was  added  to serum  R.S.  in  the 
presence of C5b-6, formation of the SC5b-9 complex occurred (Fig. 6 D). 
Discussion 
The normal C8 molecule is composed of three nonidentical polypeptide chains (10, 
12).  The  a  and  y  chains  are  covalently linked,  and  the  ~  chain  is  noncovalently 
associated with the a-y subunit. The results of the present study strongly suggest that 
the abnormal C8  found in the three C8-deficient individuals is identical to the a-y 
subunit of normal C8 and that the fl chain is missing. This conclusion is based on the 
following findings.  First,  C8  R.S.  is  identical to  a-~, of normal  C8  with  respect  to 
molecular weight,  chain  composition, electrophoretic mobility  in  SDS  gels,  amino 1604  INCOMPLETE C8  MOLECULE IN HOMOZYGOUS C8  DEFICIENCY 
TABLE  II 
Comparison of the Amino Acid Composition of C8, CSct-y, and C8a-7 R.S. 
Residue 
Amino acids/I,000 residues 
C8  C8a-y  C8a-y R.S. 
Lys  55  64  62 
His  21  24  23 
Arg  64  56  50 
Asp  97  94  98 
Thr  53  56  60 
Ser  78  80  83 
Glu  114  113  117 
Pro  41  50  48 
Gly  88  93  90 
Ala  63  71  73 
1/2 Cys*  41  29  3l 
Val  63  67  66 
Met  19  14  13 
lie  41  37  35 
Leu  75  79  79 
Tyr  45  41  41 
Phe  39  32  31 
All amino acids were determined after 24 h hydrolysis time. 
* Measured as sulfonic acid derivative. 
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C8 Depleted Serum 
Flo.  5.  Restoration  of hemolytic activity of serum  R.S.  by addition  of fl chain  isolated  from 
normal  C8.  Serum  R.S.  and  serum  immunochemically depleted of C8  were reconstituted  with 
physiological  concentrations of C8 (60 #g/ml), C8a-~, (35 ptg/ml), or C8,8 (25 #g/ml), respectively. 
Hemolytic activity was assayed as described  in Materials and Methods. 
acid composition,  and  immunochemical  and  functional  properties.  Second,  C8  S.K. 
and C8 J.C. are immunochemically  identical with C8 R.S. and all three sera could be 
restored  with  respect  to  hemolytic  activity by  addition  of isolated  CSfl.  C8a-'},  R.S. 
did not bind to EAC I-7  (6)  or SC5b-7 and was hemolytically completely inactive, in 
agreement  with  recent  findings  of Steckel  et  al.  (12),  who  have  demonstrated  that 
neither  the a-7 nor  the fl subunit  isolated  from  normal  C8  is capable  of promoting 
hemolysis.  These  investigators  have further  reported  that  the a-7 subunit  of normal TSCHOPP  ET  AL.  1605 
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FIG. 6.  Lack of binding of C8 R.S. to SC5b-7 as revealed by sucrose density gradient analysis. 
Formation of SC5b-7 or SC5b-9 complexes was achieved through reactive lysis by incubation of 
serum R.S. or CS-depleted serum with C5b-6. Aliquots of 150/~l  were layered on top of 10-40% 
linear sucrose density gradients and centrifuged for 16 h at 4°C and 160,000 gmu. (A) Formation of 
SC5b-7 by addition of 125I-C5b-6 (15/~g)  to 100/tl of CS-depleted serum. (B) Formation of SC5b-9 
by addition of C5b-6 (15 #g) and z25I-C8 02 P,g) to 100/zl of serum R.S. (C) Sedimentation behavior 
of l~I-C8 R.S. added to 100 #1 of serum R.S. (I-1) or to 100/~l buffer (O). (D) Formation of SC5b-9 
in serum  R.S.  100/tl  serum  R.S.  was  incubated with C5b-6  (15  btg), 125I-C8 (R.S.)  (l  /~g), and 
normal CSfl (2 #g). 
C8  does not bind to SC5b-7,  in contrast to the isolated fl chain, which does bind 
SC5b-7  (18). 
Our failure to detect the fl chain in the patients' sera cannot be explained by its 
loss during the course of isolation of the dysfunctional C8, because the antibody used 
in the isolation procedure recognized the fl chain of normal (28. The possibility cannot 
be excluded, however, that an immunochemically undetectable, smaller fragment of 
the fl chain is synthesized in these individuals. 
The previously reported C8 deficiencies (1-3) were characterized by an absence of 
detectable C8 protein in the individuals' serum. Although this fact had been estab- 
lished with antiserum produced in this laboratory, it was possible that the antiserum 
used  at  that  time did not  recognize the  a-7  subunit.  Retesting several  of the  C8 
deficient sera reported by Giraldo et al. (2) with anti-C8 used in this study confirmed 
the earlier results. These findings suggest that two different forms of C8 deficiency 
occur in man and therefore raise the possibility that C8 is encoded by more than one 
gene. 
Summary 
Sera from three unrelated individuals with recurrent  Neisserial infections lacked 
C8 hemolytic activity, but contained a  protein  that  is antigenically related to C8. 
Immunochemical analysis revealed complete identity of the C8-related protein of all 
three sera and a  marked antigenic deficiency compared with normal C8. The C8- 
related protein was isolated from serum by adsorption to immobilized anti-C8 IgG, 
elution with  3  M  guanidine, and subsequent  gel  filtration. Upon  sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis analysis, the abnormal protein resembled 
the a-7 subunit of normal C8 with respect to mobility and its ability to be cleaved 1606  INCOMPLETE C8  MOLECULE IN HOMOZYGOUS  C8  DEFICIENCY 
upon reduction into the a  and y chains. The 13 chain present in normal C8 was absent. 
Sedimentation  equilibrium  analysis  indicated  a  molecular  weight  of 86,000  for the 
abnormal  C8  protein,  which  is  identical  to  that  of the  a-y subunit  of normal  C8. 
Amino acid analysis revealed no significant difference between the abnormal C8 and 
normal a-y. Unlike normal C8, the abnormal protein  did not bind  to EAC1-7 or to 
SC5b-7;  however,  upon  addition  to  the  deficient  serum  of j~  chain  isolated  from 
normal  C8,  hemolytic activity was restored  and  formation of SC5b-9 occurred.  We 
concluded  that  the  dysfunctional  C8  protein  in  the  three  individuals'  serum  is 
identical  to  the  a-~,  subunit  of normal  C8  and  that  this  form  of C8  deficiency  is 
distinct  from the C8 deficiencies previously reported  in which the entire three-chain 
protein is lacking. 
Received  for publication 13July 1981. 
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